Abstract:BACKGROUND & OBJECTIVE:Cellular keratin, an indicator for cancer cell in circulation gains increasing attention. Although CK19mRNA as a gene marker used to identify micro-metastasis is of relatively high practical value, it lacks specificity and sensitivity in diagnosis of cancer. The aim of this study is to evaluate whether the combined detection of CK19mRNA with other tumor markers, such as carcinoembryanic antigen(CEA), neuron-specific Enolase(NSE), tissue polypeptide antigen(TPA), would improve the diagnosis of lung cancer. METHODS:The expression level of CK19mRNA in peripheral blood mononucleated cells (PBMCS) was determined by RT-PCR, The levels of CEA, NSE, and TPA in serum were determined by enzyme-linked immunosorbent assay (ELISA) and time-resolved fluorometry(TRF) in 91 patients with lung cancer, 33 with benign lung diseases (BLD) and 50 healthy controls. The data was analyzed by t test and chi 2 test. RESULTS:The positive rates of CK19mRNA, CEA, NSE, and TPA in lung cancer group (49.5%, 65.9%, 67.0%, and 83.5%, respectively) were remarkably higher than in BLD group(24.2%, 9.0%, 15.2%, and 9.0%, respectively) and in healthy control group (10.0%, 4.0%, 8.0%, and 6.0%, respectively) (P < 0.01). The positive rate of CK19mRNA was not statistically different in various histological subtypes (P > 0.05). Although the positive rate of CK19mRNA appeared to be associated with the clinical stage (stage I + II: 44.4%, stage III: 48.4%, stag IV: 54.2%), there was no statistical significance among the three groups (P > 0.05). The serum level (microgram/L)/positive rate of CEA(3.5/27.8%, 5.1/35.5%, and 8.5/58.3%, respectively), NSE (12.5/33.3%, 15.3/41.9%, and 24.7/58.3%, respectively), and TPA (1.1/44.4%, 1.8/58.1%, and 3.6/66.7%, respectively) in stage I + II, III, and IV appeared to be associated with the clinical stages of lung cancer, but no statistical significance among the three groups (P > 0.05). Combined detection of three or four tumor markers yielded significant higher effective accuracy in diagnosis of lung cancer than that of any of two tumor markers or single tumor marker (P < 0.05). In addition, the results showed that TPA, CEA, and NSE were relatively specific for squamous cell carcinoma (76.7%), adenocarcinomas (83.3%), and small-cell lung cancer (79.2%), respectively. CONCLUSION:The combined measurement of CK19mRNA with CEA, NSE, and TPA can increase diagnosis rate of lung cancer, can also provide potent diagnosis basis for treatment.

Clinical significance of combined detection tumor markers in patients with lung cancer

[Significance of Combined Determination of CK19mRNA, Carcinoembryanic Antigen, Neuron-Specific Enolase, and Tissue Polypeptide Antigen in Peripheral Blood of Patients with Lung Cancer].

Value of joint detection of tumor markers to the diagnosis of lung cancer

The Combination of the Tumor Markers Suggests the Histological Diagnosis of Lung Cancer

The Clinical Significance of Serum NSE, CA15-3, CEA in for the Diagnosis of Lung Cnacer

Evaluation of clinical value of combined tumor markers detection in diagnosis of lung cancer

Clinical significance of CEA and CK20 expression in exfoliated cells by fiberoptic bronchoscopy brushing

The clinical value of serum tumor markers combined PET/CT diagnosis on non-small cell lung cancer

DIAGNOSTIC VALUE OF SERUM TUMOR MARKERS FOR LUNG CANCER

Assessment of Seven Clinical Tumor Markers in Diagnosis of Non-Small-Cell Lung Cancer

The clinical value of combined detection of seven lung cancer-related autoantibodies in assisting the diagnosis of non-small-cell lung cancer

[The value of serum tumor marker in the diagnosis of lung cancer]

Lack of Efficacy of Combined Carbohydrate Antigen Markers for Lung Cancer Diagnosis

[Combined Detection of CEA Mrna and CK 19 Mrna in Peripheral Blood Cells of Patients with Lung Cancer].

Application Value of CYFRA21-1 Combined with NSE, CEA, and SCC-Ag in Lung Cancer.

Clinical Significance of Combined Diagnostic Tests of Serum Markers in Detecting Metastasis Colorectal Cancer

Clinical Significance of Combined Assay of Serum Tumor Markers in Patients with Gastrocolonic Carcinoma

The value of combined detection of CEA, CYFRA21-1, SCC-Ag, and pro-GRP in the differential diagnosis of lung cancer

Comprehensive analysis of marker gene detection and computed tomography for the diagnosis of human lung cancer

Study on the significance of tumor markers in bronchoalveolar lavage fluid for diagnosis of primary lung cancer

Serum vascular endothelial growth factor level in patients with lung cancer and breast cancer and its clinical significance